Now Available from CCO Hepatitis
 |
TREATMENT UPDATE
HBV Treatment: What to Start?
Robert G. Gish, MD, describes the latest data and reviews the most recent guidelines on the optimal selection of first-line therapy for patients with chronic hepatitis B infection. Click Here
|
Journal Options
Stay up to date with the current medical literature through a CME-certified learning module and CCO’s capsule summaries of the most relevant recently published articles with accompanying Expert Commentaries and downloadable slidesets.
Topics include:
- Telaprevir for chronic HCV genotype 1 infection
- Prolonged HCV therapy with low-dose peginterferon
- HCC in hepatitis C–related advanced liver disease
- Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin: DIRECT results
- Chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, ribavirin
- Tenofovir vs adefovir for chronic hepatitis B
- Early serum HBsAg drop and SVR in HBeAg-negative patients
- Rifaximin for hepatic encephalopathy
- Effect of fatigue on driving skills in hepatic encephalopathy patients
Treatment Update
CCO’s expert faculty members discuss the latest clinical data and best practices for selecting optimal initial HBV therapy, including a review of different initial management strategies for HBeAg-positive and HBeAg-negative patients with chronic HBV infection.
Now Available!
CME-Certified Module:
 |
HBV Treatment: What to Start? Robert G. Gish, MD, describes the latest data and reviews the most recent guidelines on the optimal selection of first-line therapy for patients with chronic hepatitis B infection. |
Downloadable CCO Slideset:
 |
HBV Treatment: What to Start? Download slide highlights from the CME-certified module on initial HBV therapies for self study and use in your own noncommercial presentations. |
CME-Certified Interactive Case Challenges:
CCO Conference Coverage
CCO's coverage of the 2009 Annual Meeting of the European Association for the Study of the Liver includes Capsule Summaries of key presentations, as well as Expert Analyses, and audio Expert Highlights that focus on key issues highlighted at the conference.
CME-Certified Expert Analyses:
Treatment Update
Through 3 Interactive Virtual Presentations, CCO’s expert faculty members review recent data and discuss critical aspects of HCV disease management, including the importance of patient quality of life, topics pertaining to patient retreatment, and strategies for minimizing cirrhosis and liver disease progression.
Now Available!
CME-Certified Interactive Virtual Presentations:
New!
Treatment Update
Expert faculty members review and explore regional and systemic treatment strategies for the clinical management of patients with hepatocellular carcinoma.
Now Available!
Video Panels:
Treatment Update
This new Treatment Update explores the role of ALT in monitoring and managing chronic hepatitis B. Discussions include the role of ALT as a marker of liver injury, the relationship between ALT levels and patient outcomes, and strategies for managing patients with normal ALT levels.
Now Available!
CME-Certified Interactive Virtual Presentation:
Downloadable CCO Slideset:
Journal Options
Topics include:
- Individualized treatment duration for hepatitis C genotype 1 patients
- Rapid virologic response and treatment duration for chronic hepatitis C genotype 1 patients
- Peginterferon alfa-2a and ribavirin in hepatitis C patients with rapid virologic response
- Randomized study of higher doses of peginterferon alfa-2a and ribavirin
- Ribavirin exposure after first dose predictive of sustained virologic response
- Resistance to nitazoxanide or tizoxanide
- Sustained HBeAg and HBsAg loss
- Sorafenib in advanced hepatocellular carcinoma
Treatment Update
This new Treatment Update provides an overview of the mechanisms by which HBV develops resistance to antiviral therapy and outlines important treatment strategies for minimizing the risk of developing HBV resistance.
Now Available!
CME-Certified Modules:
Treatment Update
In this new Treatment Update, CCO’s expert faculty members provide an overview of current approaches to the management and prevention of thrombocytopenia in the context of hepatitis C.
Now Available!
CME-Certified Module:
CME-Certified Interactive Virtual Presentation:
Downloadable Slideset:
More Treatment Update
-
-
-
-
-
HBV Core Curriculum 2008Join Robert G. Gish, MD, as he discusses the epidemiology and natural history of HBV. Then listen as Albert D. Min, MD, discusses the treatment and management of chronic hepatitis B virus infection.
More CCO Independent Conference Coverage
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
More Management Series
More Interactive Case Challenges
|
Browse Hepatitis
New Data
Slidesets
Cases
Learn about frontline regimen selection and on-treatment management of an HBeAg-positive patient and apply this learning with Albert D. Min, MD, in this Interactive Case Challenge.
Click here for more cases.
Self-Assessment
Tools
|